72 related articles for article (PubMed ID: 1576908)
1. [Inhibition of growth and metastasis of Lewis lung carcinoma in C57BL mice immunized with PGE2-bovine thyroglobulin conjugate].
Li W
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):427-9. PubMed ID: 1576908
[TBL] [Abstract][Full Text] [Related]
2. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
3. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
6. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
7. Vaccination with viable human umbilical vein endothelial cells prevents metastatic tumors by attack on tumor vasculature with both cellular and humoral immunity.
Chen XY; Zhang W; Zhang W; Wu S; Bi F; Su YJ; Tan XY; Liu JN; Zhang J
Clin Cancer Res; 2006 Oct; 12(19):5834-40. PubMed ID: 17020991
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 production by EL 4 leukemia cells from C57BL/6 mice: mechanism for tumor dissemination.
Mahan M; Meunier J; Newby M; Young MR
J Natl Cancer Inst; 1985 Jan; 74(1):191-5. PubMed ID: 3855478
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice].
Li XH; Tang L; Liu D; Sun HM; Zhou CC; Tan LS; Wang LP; Zhang PD; Zhang SQ
Ai Zheng; 2006 Oct; 25(10):1221-6. PubMed ID: 17059764
[TBL] [Abstract][Full Text] [Related]
10. Loss of metastatic and primary tumor factor X activator capabilities by Lewis lung carcinoma cells cultured in vitamin K-dependent protein deficient serum.
Fasco MJ; Eagan GE; Wilson AC; Gierthy JF; Lincoln DL
Cancer Res; 1988 Nov; 48(22):6504-9. PubMed ID: 3180067
[TBL] [Abstract][Full Text] [Related]
11. Prevention of local tumor growth with paclitaxel-loaded microspheres.
Azouz SM; Walpole J; Amirifeli S; Taylor KN; Grinstaff MW; Colson YL
J Thorac Cardiovasc Surg; 2008 May; 135(5):1014-21. PubMed ID: 18455578
[TBL] [Abstract][Full Text] [Related]
12. [Effects of suramin in combination with cisplatin on growth and metastasis of lung adenocarcinoma xenografts in mice].
Zhang P; He JB; Ou LW; Wang XH
Ai Zheng; 2006 Apr; 25(4):409-13. PubMed ID: 16613671
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of liposome-encapsulated indomethacin in response against metastatic 3LL and B16F1 tumor cells.
Aliño SF; Unda FJ; Iruarrizaga A; Alfaro J; Hilario E; Pérez-Yarza G; Bobadilla M; Lejarreta M
Lab Invest; 1992 Jun; 66(6):671-9. PubMed ID: 1602737
[TBL] [Abstract][Full Text] [Related]
14. Immunosubversive role of PGE2 in tumor bearing mice.
Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of experimental lung metastasis by aerosol delivery of PEI-p53 complexes.
Gautam A; Densmore CL; Waldrep JC
Mol Ther; 2000 Oct; 2(4):318-23. PubMed ID: 11020346
[TBL] [Abstract][Full Text] [Related]
17. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
Young MR; Young ME
Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
[TBL] [Abstract][Full Text] [Related]
18. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells.
Lee SY; Choi HK; Lee KJ; Jung JY; Hur GY; Jung KH; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Yoo SH
J Immunother; 2009 Jan; 32(1):22-8. PubMed ID: 19307990
[TBL] [Abstract][Full Text] [Related]
19. Association of increased tumor cell responsiveness to prostaglandin E2 with more aggressive tumor behavior.
Young MR; Okada F; Tada M; Hosokawa M; Kobayashi H
Invasion Metastasis; 1991; 11(1):48-57. PubMed ID: 2061004
[TBL] [Abstract][Full Text] [Related]
20. Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Sharma S; Yang SC; Zhu L; Reckamp K; Gardner B; Baratelli F; Huang M; Batra RK; Dubinett SM
Cancer Res; 2005 Jun; 65(12):5211-20. PubMed ID: 15958566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
